BioSpace News Archive

Bone Biology Market: Rising incidence of osteoporosis to drive the market

Bone biology has generated immense interest among clinicians associated with the management of bone disorders.

May 3, 2022
·
6 min read
Balloon Catheters Market: The Polyurethane Segment Is Expected to Dominate the Market in the near Future

Albany NY, United States: Balloon catheter is a delicate catheter device with an inflatable balloon at its tip which may be introduced into a duct or vessel and then blown up to clear the blockage.

May 3, 2022
·
5 min read
Back-end Revenue Cycle Management Market Growth Opportunity Analysis Report [2020-2030] – Global Industry Overview

The healthcare revenue cycle includes multiple independent yet connected segments, starting from registration to claims management, that are separated by front-end and back-end components.

May 3, 2022
·
6 min read
Poultry Vaccines Market: Rise in incidence of zoonotic diseases to drive the market

Albany NY, United States: Poultry vaccines are an important component of poultry disease prevention and control.

May 3, 2022
·
6 min read
Global Muscle Wasting Disorder Market Growth Analysis: Advancement in the Diagnostic Technologies [2020-2030]

The global muscle wasting disorder market is fueled primarily by the rising adherence to a sedentary lifestyle in developed regions.

May 3, 2022
·
6 min read
Business

Innate Pharma Announces Conference Call and Webcast for Q1 2022 Business Update

Innate Pharma SA, announced that the Company will hold a conference call on Tuesday, May 10, 2022 at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first quarter of 2022.

May 3, 2022
·
4 min read
Business

Verona Pharma Reports First Quarter 2022 Financial Results and Provides Corporate Update

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces its financial results for the three months ended March 31, 2022, and provides a corporate update.

May 3, 2022
·
13 min read
Drug Development

BioInvent’s BI-1206 to Advance into Expansion Stage of Phase 1/2a Study in NHL after a Productive End-of-Phase 1 FDA Meeting

BioInvent International AB announces its novel anti-FcyRIIB antibody BI-1206 is progressing into the expansion phase of a Phase 1/2a trial for non-Hodgkin’s lymphoma, following a positive End-of-Phase 1 meeting with the US FDA.

May 3, 2022
·
5 min read
Pancreatic Cancer Therapeutics Market: Trends, Opportunities and Regional Outlook

Albany NY, United States: Pancreatic cancer is characterized by the uncontrolled growth of cells, i.e., malignant cells in the tissues of the pancreas.

May 3, 2022
·
6 min read
Laboratory Shakers Market: Increase in the Inclination toward Automation to Drive the Market

Albany NY, United States: A laboratory equipment used to mix, agitate, or blend substances in a tube or flask by shaking them is known as laboratory shaker.

May 3, 2022
·
5 min read